Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia

Gynecologic Oncology

Volumn 121, Issue 3, 2011, Pages 537-541

  Grimm, Christoph ^a   Watrowski, Rafal ^a   Baumühlner, Konstantin ^a   Natter, Camilla ^a   Tong, Dan ^a   Wolf, Andrea ^a   Zeillinger, Robert ^a   Leodolter, Sepp ^a   Reinthaller, Alexander ^a   Hefler, Lukas ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Karl Landsteiner Institute for Gynecologic Surgery and Oncology   (Austria)

Author keywords

Cervical intraepithelial neoplasia risk; CIN; Gene; Interleukin 1; Interleukin 6; Polymorphism

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; SMOKING; UTERINE CERVIX CARCINOMA IN SITU; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAPLOTYPES; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; POLYMORPHISM, SINGLE NUCLEOTIDE; UTERINE CERVICAL NEOPLASMS;

EID: 79957497642     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.02.019     Document Type: Article

References (49)

1. D.M. Parkin, and F. Bray Chapter 2: the burden of HPV-related cancers Vaccine 24 2006 11 25
2. M.H. Schiffman, H.M. Bauer, R.N. Hoover, A.G. Glass, D.M. Cadell, and B.B. Rush Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia J. Natl Cancer Inst. 85 1993 958 964 (Pubitemid 23177581)
3. E.F. Dunne, E.R. Unger, M. Sternberg, G. McQuillan, D.C. Swan, and S.S. Patel Prevalence of HPV infection among females in the United States JAMA 297 2007 813 819 (Pubitemid 46333946)
4. P.E. Castle, D. Solomon, M. Schiffman, and C.M. Wheeler Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities J. Natl Cancer Inst. 97 2005 1066 1071 (Pubitemid 41417923)
5. M. Ricote, I. Garcia-Tunon, F.R. Bethencourt, B. Fraile, R. Paniagua, and M. Royuela Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma Cancer 100 2004 1388 1396 (Pubitemid 38366841)
6. C.A. Dinarello Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist Int. Rev. Immunol. 16 1998 457 499 (Pubitemid 28286181)
7. J. Sauer, U. Renner, U. Hopfner, M. Lange, A. Müller, and C.J. Strasburger Interleukin-1 beta enhances interleukin-1 receptor antagonist content in human somatotroph adenoma cell cultures J. Clin. Endocrinol. Metab. 83 1998 2429 2434 (Pubitemid 28503042)
8. K. Behbakht, J. Friedman, I. Heimler, A. Aroutcheva, J. Simoes, and S. Faro Role of the vaginal microbiological ecosystem and cytokine profile in the promotion of cervical dysplasia: a case-control study Infect. Dis. Obstet. Gynecol. 10 2002 181 186 (Pubitemid 36207209)
9. T.E. Belokrinitskaia, Vitkovski IuN, and Ponomareva IuN Role of cytokines in the development of immunologic and homeostatic disorders in advanced dysplasia and carcinoma of the uterine cervix Vopr. Onkol. 49 2003 51 54
10. M.Y. Tjiong, N. van der Vange, J.S. ter Schegget, M.P. Burger, F.W. ten Kate, and T.A. Out Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia Cytokine 14 2001 357 360 (Pubitemid 32730478)
11. S. Diehl, and M. Rincon The two faces of IL-6 on Th1/Th2 differentiation Mol. Immunol. 39 2002 531 536 (Pubitemid 35341492)
12. J.G. Asschert, E. Vellenga, M.H. Ruiters, and E.G. De Vries Regulation of spontaneous and TNF/IFN-induced IL-6 expression in two human ovarian-carcinoma cell lines Int. J. Cancer 82 1999 244 249 (Pubitemid 29293784)
13. S. Smola-Hess, U.S. de Silva, D. Hadaschik, and H.J. Pfister Soluble interleukin-6 receptor activates the human papillomavirus type 18 long control region in SW756 cervical carcinoma cells in a STAT3-dependent manner J. Gen. Virol. 82 2001 2335 2339 (Pubitemid 32936767)
14. S. Hess, H. Smola, U. Sandaradura De Silva, D. Hadaschik, D. Kube, and S.E. Baldus Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: abrogation of constitutive monocyte chemoattractant protein-1 production J. Immunol. 165 2000 1939 1948 (Pubitemid 30643145)
15. W.P. Arend The balance between IL-1 and IL-1Ra in disease Cytokine Growth Factor Rev. 13 2002 323 340
16. R. Salgado, I. Benoy, R. Weytjens, D. Van Bockstaele, E. Van Marck, and P. Huget Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer Br. J. Cancer 87 2002 1437 1444 (Pubitemid 36044320)
17. L.H. Wei, M.L. Kuo, C.A. Chen, C.H. Chou, K.B. Lai, and C.N. Lee Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway Oncogene 22 2003 1517 1527
18. S. Nozaki, G.W. Sledge Jr., and H. Nakshatri Cancer cell-derived interleukin 1 alpha contributes to autocrine and paracrine induction of prometastatic genes in breast cancer Biochem. Biophys. Res. Commun. 275 2000 60 62 (Pubitemid 30663629)
19. J.S. Wolf, Z. Chen, G. Dong, J.B. Sunwoo, C.C. Bancroft, and D.E. Capo IL (Interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas Clin. Cancer Res. 7 2001 1812 1820 (Pubitemid 32708653)
20. J.L. Su, K.P. Lai, C.A. Chen, C.Y. Yang, P.S. Chen, and C.C. Chang A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth Cancer Res. 65 2005 4827 4835
21. R. Srivani, and B. Nagarajan A prognostic insight on in vivo expression of interleukin-6 in uterine cervical cancer Int. J. Gynecol. Cancer 13 2003 331 339 (Pubitemid 38222583)
22. R. Fujiwaki, K. Iida, K. Nakayama, H. Kanasaki, K. Hata, and H. Katabuchi Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinoma Gynecol. Oncol. 89 2003 77 83 (Pubitemid 36403650)
23. C.A. Dinarello Biologic basis for interleukin-1 in disease Blood 87 1996 2095 2147 (Pubitemid 26086851)
24. F. Pociot, J. Molvig, L. Wogensen, H. Worsaae, and J. Nerup TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro Eur. J. Clin. Invest. 22 1992 396 402
25. F.S. di Giovine, E. Takhsh, A.L. Blakemore, and G.W. Duff Single base polymorphism at - 511 in the human interleukin-1 beta gene (IL1 beta) Hum. Mol. Genet. 1 1992 450
26. J. Hulkkonen, P. Laippala, and M. Hurme A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals Eur. Cytokine Netw. 11 2000 251 255
27. V.A. Danis, M. Millington, V.J. Hyland, and D. Grennan Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism Clin. Exp. Immunol. 99 1995 303 310
28. R. Dewberry, H. Holden, D. Crossman, and S. Francis Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis Arterioscler. Thromb. Vasc. Biol. 20 2000 2394 2400
29. A.M. Bowcock, J.R. Kidd, G.M. Lathrop, L. Daneshvar, L.T. May, and A. Ray The human "interferon-beta 2/hepatocyte stimulating factor/interleukin- 6" gene: DNA polymorphism studies and localization to chromosome 7p21 Genomics 3 1988 8 16
30. M.A. Vickers, F.R. Green, C. Terry, B.M. Mayosi, C. Julier, and M. Lathrop Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein Cardiovasc. Res. 53 2002 1029 1034 (Pubitemid 34261041)
31. S.A. Jones, S. Horiuchi, N. Topley, N. Yamamoto, and G.M. Fuller The soluble interleukin 6 receptor: mechanisms of production and implications in disease FASEB J. 15 2001 43 58 (Pubitemid 32061655)
32. E. Tartour, A. Gey, X. Sastre-Garau, C. Pannetier, V. Mosseri, and P. Kourilsky Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma Cancer Res. 54 1994 6243 6248 (Pubitemid 24378660)
33. H. Singh, R. Sachan, H. Goel, and B. Mittal Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer BJOG 115 2008 633 638 (Pubitemid 351357571)
34. A. Mustea, J. Sehouli, D. Konsgen, D. Stengel, D. Sofroni, and W. Lichtenegger Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer Anticancer Res. 23 2003 1099 1102 (Pubitemid 36752683)
35. R.C. Sobti, D.M. Kordi Tamandani, M. Shekari, P. Kaur, K. Malekzadeh, and V. Suri Interleukin 1 beta gene polymorphism and risk of cervical cancer Int. J. Gynaecol. Obstet. 101 2008 47 52
36. N.C. Nogueira de Souza, S.M. Brenna, F. Campos, K.J. Syrjänen, E.C. Baracat, and I.D. Silva Interleukin-6 polymorphisms and the risk of cervical cancer Int. J. Gynecol. Cancer 16 2006 1278 1282 (Pubitemid 43886757)
37. R. Gangwar, B. Mittal, and R.D. Mittal Association of interleukin-6-174G > C promoter polymorphism with risk of cervical cancer Int. J. Biol. Markers 24 2009 11 16
38. C. Grimm, I. Berger, C. Tomovski, R. Zeillinger, N. Concin, and S. Leodolter A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesis Gynecol. Oncol. 92 2004 936 940 (Pubitemid 38251399)
39. C. Grimm, L. Six, C. Tomovski, P. Speiser, E. Joura, and R. Zeillinger A common interleukin-6 promoter polymorphism in patients with vulvar cancer J. Soc. Gynecol. Investig. 12 2005 617 620 (Pubitemid 41737728)
40. D. Abazis-Stamboulieh, P. Oikonomou, N. Papadoulis, P. Panayiotidis, E. Vrakidou, and A. Tsezou Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma Leuk. Lymphoma 48 2007 2196 2203 (Pubitemid 350091062)
41. G. Endler, R. Marculescu, P. Starkl, A. Binder, G. Geishofer, and M. Müller Polymorphisms in the interleukin-1 gene cluster in children and young adults with systemic meningococcemia Clin. Chem. 52 2006 511 514
42. M.U. Uboldi de Capei, E. Dametto, M.E. Fasano, S. Rendine, and E.S. Curtoni Genotyping for cytokine polymorphisms: allele frequencies in the Italian population Eur. J. Immunogenet 30 2003 5 10 (Pubitemid 36241236)
43. S.E. Marshall, A.J. McLaren, E.F. McKinney, T.G. Bird, N.A. Haldar, and M. Bunce Donor cytokine genotype influences the development of acute rejection after renal transplantation Transplantation 71 2001 469 476 (Pubitemid 32175987)
44. S. Shirodaria, J. Smith, I.J. McKay, C.N. Kennett, and F.J. Hughes Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease J. Dent. Res. 79 2000 1864 1869 (Pubitemid 32489353)
45. R.N. Apte, S. Dotan, M. Elkabets, M.R. White, E. Reich, and Y. Carmi The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions Cancer Metastasis Rev. 25 2006 387 408 (Pubitemid 44922357)
46. F.A. Castro, K. Haimila, I. Sareneva, M. Schmitt, J. Lorenzo, and N. Kunkel Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population-a candidate gene approach Int. J. Cancer 125 2009 1851 1858
47. G.Y. Ho, R.D. Burk, S. Klein, A.S. Kadish, C.J. Chang, and P. Palan Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia J. Natl Cancer Inst. 87 1995 1365 1371
48. A.B. Moscicki, N. Hills, S. Shiboski, K. Powell, N. Jay, and E. Hanson Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females JAMA 285 2001 2995 3002 (Pubitemid 32550118)
49. K. McIntyre-Seltman, P.E. Castle, R. Guido, M. Schiffman ALTS Group Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology Cancer Epidemiol. Biomark. Prev. 14 2005 1165 1170 (Pubitemid 40656462)